New therapies & advancements for low-risk MDS by consultant haematologist Dr. Beth Payne
12 Mar. 2025
Dr Beth Payne is a consultant haematologist at University College London Hospital and an associate professor at University College London, who specialises in the treatment of MDS and bone marrow failure. The recording below is a of a Zoom presentation she gave to the MDS UK Support Group on March 5th 2025 on ' New therapies and advancements in treating low-risk Myelodysplastic Syndromes (MDS) to improve patient outcomes'.
Watch: Dr. Beth Payne’s presentation, "New Therapies & Advancements for Low-Risk MDS,"
Dr. Beth Payne, consultant haematologist at UCLH
Dr Beth Payne specialises in the treatment of MDS and bone marrow failure. She undertook her PhD at the Dana-Farber Cancer Institute, Harvard Medical School in Boston USA, studying molecular aspects of MDS and AML and ribosomal protein mediated disorders. She was awarded an Advanced Clinician Scientist Fellowship by Cancer Research UK.
